| OAA0403 | In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014 | Oral abstract session with live Q&A | Strategies to reduce/eliminate viral reservoirs |
| EPB123 | Incidence and disease severity of non-alcoholic fatty liver disease among people living with HIV in Thailand | E-poster | Hepatic complications (e.g., NASH) |
| EPC089 | Incidence and predictors of clinical bone fractures among people with HIV on antiretroviral therapy | E-poster | Epidemiology of non-AIDS non-communicable diseases (e.g., non-AIDS cancers, CVD) |
| EPB034 | Incidence and risk factors for liver enzyme elevation in HIV-1 infected patients treated for tuberculosis: a secondary analysis of the multi-country ANRS 12300 REFLATE TB2 trial | E-poster | Tuberculosis: Prevention, diagnosis, treatment |
| PESUB15 | Incidence of and risk factors for heart failure subtypes in women and men living with HIV | Poster exhibition | Cardiovascular disease |
| EPB108 | Incidence of cardiometabolic outcomes among people living with HIV initiated on INSTI versus non-INSTI antiretroviral therapies | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
| PESAC12 | Incidence of HCV reinfection among people with HIV prior to and during periods of limited and broad access to direct-acting antiviral therapies for HCV in five countries | Poster exhibition | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
| EPC201 | Incidence of HIV infection after initiation of Australian government-subsidisedpre-exposure prophylaxis (PrEP): a national whole-of-population cohort study using dispensing data | E-poster | Scale up of PrEP |
| EPC115 | Incidence of HIV infection and its burden of transmission among populations: a case study of Jos, North-Central Nigeria | E-poster | Determining the incidence of HIV |
| EPC077 | Incidence of sexually transmitted infections among adolescent's men who have sex with men and transgender women enrolled in a PrEP cohort study in Brazil | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |